J2313
HCPCSInj, naloxone (zimhi) 0.01mg
Official HCPCS Level II long descriptor
Injection, naloxone hydrochloride (zimhi), 0.01 mg
HCPCS Level II code J2313 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, naloxone (zimhi) 0.01mg
Added to HCPCS: 2025-07-01
Nearby codes in J2
- J2278Ziconotide injection
- J2280Inj, moxifloxacin 100 mg
- J2281Inj moxifloxacin (fres kabi)
- J2290Inj, nafcillin sodium, 20 mg
- J2291Inj, nafcillin (baxter) 20mg
- J2300Inj nalbuphine hydrochloride
- J2305Inj, nitroglycerin, 5 mg
- J2312Inj naloxone hcl nos, 0.01mg
- J2315Naltrexone, depot form
- J2320Nandrolone decanoate 50 mg
- J2323Natalizumab injection
- J2325Nesiritide injection
- J2326Inj, nusinersen, 0.1mg
- J2327Inj risankizumab-rzaa 1 mg
- J2329Inj ublituximab-xiiy, 1 mg
- J2350Injection, ocrelizumab, 1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.